NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 737.00
-55.00 (-6.94%)
At close: Jun 22, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 19.76 billion as of June 30, 2026. Its market cap has decreased by -51.60% in one year.
Market Cap
19.76B
Enterprise Value
45.58B
Revenue
31.20B
Ranking
n/a
PE Ratio
n/a
Stock Price
737.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 19.76B, a decrease of -93.69%. That is a compound annual growth rate of -39.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 19.76B | -45.95% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J2KBIO | 42.10B |
| HLB Pep | 40.69B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Quratis | 34.83B |
| Epibiotech | 29.99B |
| Shaperon | 26.27B |
| Poongjeon Pharmacy CO.,LTD. | 23.34B |